Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- PacificHealth Laboratories Announces Sale of Sports Drink Assets to Mott's LLP
Company announces that Mott's LLP, has purchased the trademarks, technology and patents for their brands, Accelerade(R) and Endurox (R) R4 (R), in return for a $4 million upfront payment and a royalty based on sales for a defined period. PacificHealth Laboratories was granted an exclusive royalty-free license to use the intellectual property and trademarks for the continued manufacture, distribution and marketing of Accelerade and Endurox R4 brands in powder and gel forms.
- PacificHealth Laboratories Announces Sale of Sports Drink Assets to Mott's LLP
Company announces that Mott's LLP, has purchased the trademarks, technology and patents for their brands, Accelerade(R) and Endurox (R) R4 (R), in return for a $4 million upfront payment and a royalty based on sales for a defined period. PacificHealth Laboratories was granted an exclusive royalty-free license to use the intellectual property and trademarks for the continued manufacture, distribution and marketing of Accelerade and Endurox R4 brands in powder and gel forms.
- Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm)
Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years.
- Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm)
Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years.
- Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm)
Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years.
- Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm)
Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years.
- Burcon granted two U.S. patents
Company receives United States Patent Number 6,992,173 B2 - "Protein Extraction from Canola Oil Seed Meal" - covering an improved process for the recovery of protein from canola oil seed meal and other oil seed meals, and United States Patent Number 7,001,990 - "Canola Protein Isolate Functionality II" - covering a protein isolate, obtained from canola oil seed meal, as a functional component in food compositions.
- Burcon granted two U.S. patents
Company receives United States Patent Number 6,992,173 B2 - "Protein Extraction from Canola Oil Seed Meal" - covering an improved process for the recovery of protein from canola oil seed meal and other oil seed meals, and United States Patent Number 7,001,990 - "Canola Protein Isolate Functionality II" - covering a protein isolate, obtained from canola oil seed meal, as a functional component in food compositions.
- Investment To Enable Functional Foods Clinical Trials for Vital Foods
BioPacificVentures (BPV), the $100 million Australasian food, health and agbio venture capital fund, is leading a $4 million investment round in the Auckland-based functional food manufacturer Vital Food Processors Ltd with Seeka Kiwifruit Industries Ltd as co-investor, allowing Vital to conduct clinical trials with its products for digestive disorders and to expand its international marketing.
- Investment To Enable Functional Foods Clinical Trials for Vital Foods
BioPacificVentures (BPV), the $100 million Australasian food, health and agbio venture capital fund, is leading a $4 million investment round in the Auckland-based functional food manufacturer Vital Food Processors Ltd with Seeka Kiwifruit Industries Ltd as co-investor, allowing Vital to conduct clinical trials with its products for digestive disorders and to expand its international marketing.
- Advitech’s Dermylex(TM) To Be Marketed by PhotoMedex in five U.S. areas by end of February 2006
PhotoMedex Inc. will pre-launch Dermylex(TM) in five U.S. areas (San Francisco, CA, Los Angeles, CA, Dallas, TX, New York, NY and Cleveland, OH) during the last week of February 2006, will also introduce Dermylex™ at the American Academy of Dermatology (AAD) Conference.
- Advitech’s Dermylex(TM) To Be Marketed by PhotoMedex in five U.S. areas by end of February 2006
PhotoMedex Inc. will pre-launch Dermylex(TM) in five U.S. areas (San Francisco, CA, Los Angeles, CA, Dallas, TX, New York, NY and Cleveland, OH) during the last week of February 2006, will also introduce Dermylex™ at the American Academy of Dermatology (AAD) Conference.
- Atrium Reports Fiscal 2005 Results
Company reports revenues of US$201 million for the year ended December 31, 2005, up 47% from US$136 million for the corresponding previous fiscal year, with net earnings increasing 42% to US$14.3 million for the year ended December 31, 2005, compared to US$10.1 million for the same period last year.
- Atrium Reports Fiscal 2005 Results
Company reports revenues of US$201 million for the year ended December 31, 2005, up 47% from US$136 million for the corresponding previous fiscal year, with net earnings increasing 42% to US$14.3 million for the year ended December 31, 2005, compared to US$10.1 million for the same period last year.
- Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors
Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors.
- Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors
Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors.
- Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors
Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors.
- Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors
Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors.
- EPAX AS Announces De-merger with Pronova Biocare
EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name.
- EPAX AS Announces De-merger with Pronova Biocare
EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name.
- EPAX AS Announces De-merger with Pronova Biocare
EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name.
- EPAX AS Announces De-merger with Pronova Biocare
EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name.
- EPAX AS Announces De-merger with Pronova Biocare
EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name.
- Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors
Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors.
- Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors
Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors.
- Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors
Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors.
- Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors
Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors.
- Reliv International Announces 2005 and Q4 Results
Company reports Q4 net income of $1.81 million, or $0.11 per share (diluted), compared to $1.28 million, or $0.07 per share (diluted) in the prior-year period, on sales of $27.5 million, compared to $25.4 million in the fourth quarter of 2004.
- Reliv International Announces 2005 and Q4 Results
Company reports Q4 net income of $1.81 million, or $0.11 per share (diluted), compared to $1.28 million, or $0.07 per share (diluted) in the prior-year period, on sales of $27.5 million, compared to $25.4 million in the fourth quarter of 2004.
- Planet Organic Health Corp Announces Second Quarter Results
Company reports net income of $498,966 versus a loss of ($69,393) for the same period last year, on sales of $9.1 million for the period; an increase of 51.7%.
- Planet Organic Health Corp Announces Second Quarter Results
Company reports net income of $498,966 versus a loss of ($69,393) for the same period last year, on sales of $9.1 million for the period; an increase of 51.7%.
- NutraCea Announces Kody Newland Senior Vice President of Sales
Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets.
- NutraCea Announces Kody Newland Senior Vice President of Sales
Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets.
- NutraCea Announces Kody Newland Senior Vice President of Sales
Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets.
- NutraCea Announces Kody Newland Senior Vice President of Sales
Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets.
- Martek Announces First Quarter Financial Results
Company reports revenues of $62.9 million compared to $66.5 million for the first quarter of fiscal 05, with net income of $5.6 million, or $0.17 per diluted share compared to net income of $7.1 million, or $0.23 per diluted share for FY05 Q1.
- Martek Announces First Quarter Financial Results
Company reports revenues of $62.9 million compared to $66.5 million for the first quarter of fiscal 05, with net income of $5.6 million, or $0.17 per diluted share compared to net income of $7.1 million, or $0.23 per diluted share for FY05 Q1.
- Tate & Lyle PLC invests in a Sugar plant in Israel
Tate & Lyle will acquire 65% equity in the new Company, the net assets of which will be £8.1m ($14.3m).
- Tate & Lyle PLC invests in a Sugar plant in Israel
Tate & Lyle will acquire 65% equity in the new Company, the net assets of which will be £8.1m ($14.3m).
- Mannatech Reports Sales & Earnings for 2005
Company reports consolidated net sales of $389 million compared to $295 million in 2004, with Q4 sales increasing to $101 million as compared to $84 million for the same period in 2004.
- Mannatech Reports Sales & Earnings for 2005
Company reports consolidated net sales of $389 million compared to $295 million in 2004, with Q4 sales increasing to $101 million as compared to $84 million for the same period in 2004.
- Hansen Natural Corporation Reports Financial Results for 2005 Year
Company reports 2005 gross sales of $415.4 million compared to $224.1 million in 2004, with net income of $62.8 million, or $2.59 per diluted share, compared to $20.4 million, or $0.86 per diluted share, a year ago.
- Hansen Natural Corporation Reports Financial Results for 2005 Year
Company reports 2005 gross sales of $415.4 million compared to $224.1 million in 2004, with net income of $62.8 million, or $2.59 per diluted share, compared to $20.4 million, or $0.86 per diluted share, a year ago.
- Biogaia Signs Agreement With Forest Laboratories
Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland.
- Biogaia Signs Agreement With Forest Laboratories
Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland.
- Biogaia Signs Agreement With Forest Laboratories
Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland.
- Biogaia Signs Agreement With Forest Laboratories
Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland.
- Biogaia Signs Agreement With Forest Laboratories
Company has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited giving Forest the exclusive rights to sell BioGaia's Reuteri Drops in Great Britain and Ireland.
- Neptune Technologies & Bioressources Inc. Announces Breakthrough in the Functional Food Industry
Company enters functional food market through alliance with three confectionaries produced with three different fresh fruits; pomegranate, passion-fruit and mango, a tablespoon of each containing a 300mg dose of Neptune Krill Oil "NKO(TM)" .
- Neptune Technologies & Bioressources Inc. Announces Breakthrough in the Functional Food Industry
Company enters functional food market through alliance with three confectionaries produced with three different fresh fruits; pomegranate, passion-fruit and mango, a tablespoon of each containing a 300mg dose of Neptune Krill Oil "NKO(TM)" .
- Neptune Technologies & Bioressources Inc. Announces Breakthrough in the Functional Food Industry
Company enters functional food market through alliance with three confectionaries produced with three different fresh fruits; pomegranate, passion-fruit and mango, a tablespoon of each containing a 300mg dose of Neptune Krill Oil "NKO(TM)" .
- Neptune Technologies & Bioressources Inc. Announces Breakthrough in the Functional Food Industry
Company enters functional food market through alliance with three confectionaries produced with three different fresh fruits; pomegranate, passion-fruit and mango, a tablespoon of each containing a 300mg dose of Neptune Krill Oil "NKO(TM)" .
- Neptune Technologies & Bioressources Inc. Announces Breakthrough in the Functional Food Industry
Company enters functional food market through alliance with three confectionaries produced with three different fresh fruits; pomegranate, passion-fruit and mango, a tablespoon of each containing a 300mg dose of Neptune Krill Oil "NKO(TM)" .
- Neptune Technologies & Bioressources Inc. Announces Breakthrough in the Functional Food Industry
Company enters functional food market through alliance with three confectionaries produced with three different fresh fruits; pomegranate, passion-fruit and mango, a tablespoon of each containing a 300mg dose of Neptune Krill Oil "NKO(TM)" .
- Biogaia Signs Agreement With Ferring Pharmaceuticals
Company has entered into an agreement with the Swiss pharmaceutical company Ferring Pharmaceuticals giving Ferring exclusive rights to sell BioGaia's Reuteri drops in Spain, Portugal, Czech Republic and Hungary plus optional rights to several other countries.
- Biogaia Signs Agreement With Ferring Pharmaceuticals
Company has entered into an agreement with the Swiss pharmaceutical company Ferring Pharmaceuticals giving Ferring exclusive rights to sell BioGaia's Reuteri drops in Spain, Portugal, Czech Republic and Hungary plus optional rights to several other countries.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced today the appointment of P.L. Thomas as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced today the appointment of P.L. Thomas as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Zila Releases Its Fiscal 2006 Second Quarter Financial Results
Company reports net revenues of $9.6 million compared to $10.9 million prior year, with Nutraceuticals revenue declining 2.6 million, or 26%, due to slower factory sales.
- Zila Releases Its Fiscal 2006 Second Quarter Financial Results
Company reports net revenues of $9.6 million compared to $10.9 million prior year, with Nutraceuticals revenue declining 2.6 million, or 26%, due to slower factory sales.
- Frutarom Reports 2005 Results
Company reports FY05 sales of US$ 243.8 million, a 23.9% increase compared with 2004, when sales reached US$ 196.8 million, as gross profit for the period rose 27% to reach US$ 94.5 million compared with US$ 74.3 million prior year.
- Frutarom Reports 2005 Results
Company reports FY05 sales of US$ 243.8 million, a 23.9% increase compared with 2004, when sales reached US$ 196.8 million, as gross profit for the period rose 27% to reach US$ 94.5 million compared with US$ 74.3 million prior year.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Mar 03, 2006 /PRNewswire-FirstCall via COMTEX/ -- The Hain Celestial Group, Inc. (HAIN) today announced the acquisition of the business and assets of Para Laboratories, Inc. including the Queen Helene(R), Batherapy(R) and Footherapy(R) brands. A respected leader in quality health and beauty products for professional and personal use since 1930, Para Labs offers skin care, hair care and body care products through drug stores, supermarkets and mass retailers. Para Labs' product line complements Hain Celestial's Jason(R) natural and organic oral, body and hair care, Zia(R) premium skin care and Earth's Best(R) baby body care in the fast-growing natural health and personal care products category. In its last fiscal year, Para Laboratories sales totaled approximately $20 million. The terms of the acquisition, which closed on March 3, 2006, were not disclosed. The transaction is expected to be accretive to Hain Celestial's earnings during its fiscal year 2007.
"I am excited about the great brands Para Labs adds to our growing portfolio of personal care products," said Irwin D. Simon, President and Chief Executive Officer of The Hain Celestial Group. "The acquisition of these brands brings us closer to our objective to build a $100 million Personal Care business through internal growth and acquisitions, as this is our third acquisition in the personal care products category since June 2004. The distribution of these brands in chain drug and mass channels will enable us to extend our other products in those channels with our Jason, Zia and Earth's Best brands. We are also pleased to expand our management team under Andrew H. Jacobson as the third generation from Para Labs, Steve Estrin and Joel Estrin, join us in executive positions in Personal Care," concluded Irwin Simon.
Hain Celestial has built a substantial presence in personal care to complement its leading presence in natural and organic foods. Hain Celestial is committed to creating and promoting A Healthy Way of Life(TM).
The Hain Celestial Group The Hain Celestial Group (HAIN) , headquartered in Melville, NY, is a leading natural and organic food and personal care products company in North America and Europe. Hain Celestial participates in almost all natural food categories with well-known brands that include Celestial Seasonings(R), Terra Chips(R), Garden of Eatin'(R), Health Valley(R), WestSoy(R), Earth's Best(R), Arrowhead Mills(R), Estee(R), DeBoles(R), Hain Pure Foods(R), Raised Right(TM), Hollywood(R), Spectrum Naturals(R), Spectrum Essentials(R), Walnut Acres Organic(TM), Imagine Foods(R), Rice Dream(R), Soy Dream(R), Rosetto(R), Ethnic Gourmet(R), Yves Veggie Cuisine(R), Lima(R), Biomarche(TM), Grains Noirs(R), Natumi(R), JASON(R) and Zia(R) Natural Skincare. For more information, visit www.hain-celestial.com.
Safe Harbor Statement This press release contains forward-looking statements within and constitutes a "Safe Harbor" statement under the Private Securities Litigation Act of 1995. Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve known and unknown risks and uncertainties, which could cause our actual results to differ materially from those described in the forward-looking statements. These risks include but are not limited to general economic and business conditions; the ability to implement business and acquisition strategies, integrate acquisitions, and obtain financing for general corporate purposes; competition; retention of key personnel; compliance with government regulations and other risks detailed from time-to-time in the Company's reports filed with the Securities and Exchange Commission, including the report on Form 10-K for the fiscal year ended June 30, 2005. The forward-looking statements made in this press release are current as of the date of this press release, and the Company does not undertake any obligation to update forward-looking statements. |